tirzepatide surpass-4 for diabetes: on track to SURPASS current therapy Tirzepatide Forte Flex-Dose 4 mL

doi: 10.1166/jnn.2020.17486, 105

Pancreatitis, or inflammation of the pancreas, has been reported in some patients taking GLP-1 medications

Seminal work by Ahmed et al

Regular monitoring of renal function is advisable in patients with pre-existing kidney disease, as gastrointestinal adverse effects may lead to dehydration and acute kidney injury

The pipeline of major drugs losing exclusivity between 2025 and 2030 represents an estimated $300 billion or more in branded pharmaceutical revenues that will be exposed to generic or biosimilar competition [35]

Stay hydrated and eat balanced meals to support your overall health